Anika Therapeutics Inc
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-op… Read more
Anika Therapeutics Inc (ANIK) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.032x
Based on the latest financial reports, Anika Therapeutics Inc (ANIK) has a cash flow conversion efficiency ratio of 0.032x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.64 Million) by net assets ($143.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anika Therapeutics Inc - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how Anika Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Anika Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anika Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong AVCiT Tech Hldg Co
SHE:001229
|
0.026x |
|
Hubei Goto Biopharm Co.Ltd.
SHE:300966
|
0.000x |
|
Zhejiang East Asia Pharmaceutical Co. Ltd.
SHG:605177
|
-0.008x |
|
LUBAWA SA
WAR:LBW
|
0.058x |
|
Addcn Technology Co Ltd
TWO:5287
|
0.103x |
|
Loandepot Inc
NYSE:LDI
|
0.100x |
|
Reading International B Inc
NASDAQ:RDIB
|
-0.020x |
|
Fedbank Financial Services Limited
NSE:FEDFINA
|
0.039x |
Annual Cash Flow Conversion Efficiency for Anika Therapeutics Inc (1993–2025)
The table below shows the annual cash flow conversion efficiency of Anika Therapeutics Inc from 1993 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $143.47 Million | $11.19 Million | 0.078x | +122.26% |
| 2024-12-31 | $153.99 Million | $5.40 Million | 0.035x | +516.54% |
| 2023-12-31 | $212.26 Million | $-1.79 Million | -0.008x | -154.56% |
| 2022-12-31 | $285.56 Million | $4.41 Million | 0.015x | -47.21% |
| 2021-12-31 | $287.08 Million | $8.40 Million | 0.029x | -39.02% |
| 2020-12-31 | $272.40 Million | $13.06 Million | 0.048x | -62.62% |
| 2019-12-31 | $288.38 Million | $37.01 Million | 0.128x | -3.12% |
| 2018-12-31 | $263.61 Million | $34.92 Million | 0.132x | -14.48% |
| 2017-12-31 | $263.49 Million | $40.81 Million | 0.155x | +44.97% |
| 2016-12-31 | $222.77 Million | $23.80 Million | 0.107x | -42.33% |
| 2015-12-31 | $210.85 Million | $39.06 Million | 0.185x | -17.46% |
| 2014-12-31 | $178.10 Million | $39.98 Million | 0.224x | +20.99% |
| 2013-12-31 | $135.63 Million | $25.16 Million | 0.186x | +91.58% |
| 2012-12-31 | $108.93 Million | $10.55 Million | 0.097x | -9.79% |
| 2011-12-31 | $94.76 Million | $10.17 Million | 0.107x | +16.45% |
| 2010-12-31 | $85.19 Million | $7.85 Million | 0.092x | +144.70% |
| 2009-12-31 | $82.14 Million | $3.09 Million | 0.038x | -32.82% |
| 2008-12-31 | $60.76 Million | $3.41 Million | 0.056x | -31.39% |
| 2007-12-31 | $54.96 Million | $4.49 Million | 0.082x | +85.81% |
| 2006-12-31 | $45.49 Million | $2.00 Million | 0.044x | -74.16% |
| 2005-12-31 | $37.89 Million | $6.45 Million | 0.170x | -78.30% |
| 2004-12-31 | $30.36 Million | $23.82 Million | 0.785x | +601.34% |
| 2003-12-31 | $17.98 Million | $2.01 Million | 0.112x | +474.96% |
| 2002-12-31 | $17.06 Million | $332.03K | 0.019x | +109.07% |
| 2001-12-31 | $20.10 Million | $-4.31 Million | -0.215x | -204.37% |
| 2000-12-31 | $26.71 Million | $-1.88 Million | -0.071x | -326.50% |
| 1999-12-31 | $25.70 Million | $800.00K | 0.031x | -72.63% |
| 1998-12-31 | $29.90 Million | $3.40 Million | 0.114x | +14.59% |
| 1997-12-31 | $26.20 Million | $2.60 Million | 0.099x | +145.11% |
| 1996-12-31 | $5.00 Million | $-1.10 Million | -0.220x | +24.94% |
| 1995-12-31 | $5.80 Million | $-1.70 Million | -0.293x | +34.05% |
| 1994-12-31 | $5.40 Million | $-2.40 Million | -0.444x | -495.56% |
| 1993-12-31 | $6.70 Million | $-500.00K | -0.075x | -- |